• PNU 74654: Designing Better Wnt Assays

  2026-08-12

  PNU 74654 is a Wnt signaling pathway inhibitor for testing how β-catenin-dependent signals shape cell fate. This guide focuses on causal assay design, controls, and responsible interpretation across cancer research, stem cell research, and muscle biology.

• Praeruptorin A, DMT1, and Ferroptosis in DIC

  2026-08-12

  This study used a ferrous-ion probe to screen herbal small molecules and identified Praeruptorin A as an intervention candidate for doxorubicin-induced cardiomyopathy. The evidence connects Praeruptorin A with reduced DMT1 expression, lower cardiomyocyte Fe2+ overload, suppressed ferroptosis, improved cardiac function, and retained doxorubicin antitumor activity.

• ABT-263 (Navitoclax) Apoptosis Workflow

  2026-08-11

  Build more informative apoptosis assays with ABT-263 (Navitoclax), from dose-response screening to mitochondrial mechanism validation. This workflow also translates a senescence-selective study into practical controls without overstating what Navitoclax has demonstrated in non-cancer tissues.

• CD28–ARS2–PKM2 Axis in CD8+ T Cells

  2026-08-11

  Holling and colleagues identify a CD28–ARS2 signaling axis that reshapes alternative splicing of PKM in activated CD8+ T cells, favoring PKM2 over PKM1. The work connects costimulation, RNA processing, glucose-use flexibility, interferon-γ production, and antitumor effector activity through a mechanism that is distinct from canonical CD28–PI3K signaling.

• Cardiogreen: From Vascular Imaging to PDT

  2026-08-10

  Cardiogreen, also known as Indocyanine green, connects vascular diagnostics with near-infrared therapeutic research. This guide translates its optical properties into practical workflows for cardiac output measurement, liver blood flow assessment, ophthalmic angiography, and photothermal or photodynamic assays in cancer models.

• U0126-EtOH: MEK1/2 Inhibitor Workflows

  2026-08-09

  U0126-EtOH provides a practical way to interrogate MEK1/2-dependent ERK signaling across neuronal, inflammatory, and leukemia models. This guide translates pathway selectivity into executable workflows, assay controls, and troubleshooting decisions for oxidative stress research and mechanistic cell biology.

• Hexa-Acylated LPS and Cancer Immunotherapy Response

  2026-08-08

  A 2025 Nature Microbiology study identifies the structure of gut microbiota-derived lipopolysaccharide, rather than bacterial taxonomy alone, as a functional determinant of anti-PD-1 response. Patient metagenomics, immune assays, and mouse tumor experiments show that hexa-acylated LPS activates TLR4-dependent immunity and can enhance checkpoint blockade efficacy.

• AZD8055: Practical mTOR Inhibitor Guide

  2026-08-07

  AZD8055 is an ATP-competitive mTOR inhibitor for examining mTORC1 and mTORC2 signaling in cellular and preclinical models. It is suited to mechanistic cancer and metabolic research, but should not be used as evidence of clinical efficacy or where aqueous solubility is required.

• AZD6482: Selective PI3Kβ Inhibitor for Metabolic and Platele

  2026-08-07

  AZD6482 is a potent and highly selective PI3Kβ inhibitor with nanomolar efficacy and substantial isoform specificity. It is validated for use in metabolic, platelet aggregation, and anti-thrombotic studies, offering reliable, reproducible results for advanced pathway research.

• Imatinib (STI571): Unraveling NETs and Tyrosine Kinase Signa

  2026-08-06

  Explore how Imatinib (STI571) advances research into tyrosine kinase signaling and neutrophil extracellular traps (NETs) in chronic myeloid leukemia. This article uniquely bridges kinase pathway inhibition with emerging NET biology insights for translational assay innovation.

• FXR-KLF11 Axis Suppresses JAK2/STAT3 in CI-AKI: Mechanistic

  2026-08-06

  This study uncovers how Chenodeoxycholic Acid (CDCA), a natural FXR agonist, confers protection against contrast-induced acute kidney injury (CI-AKI) by transcriptionally activating KLF11 and suppressing the JAK2/STAT3 pathway. These findings clarify a mechanistic link between bile acid metabolism and nephroprotection, informing future research targeting nuclear receptor signaling in kidney injury.

• p-Cresyl Sulfate: Mechanistic Leverage for Translational Car

  2026-08-05

  This article delivers a strategic synthesis for translational researchers seeking to bridge endothelial dysfunction and vascular calcification assays with actionable mechanistic insights on p-Cresyl sulfate (p-tolyl hydrogen sulfate). Drawing on recent breakthroughs in klotho/SIRT1 signaling, it contextualizes APExBIO’s p-Cresyl sulfate as a validated, high-fidelity tool for modeling uremic toxin-driven cardiovascular risk—moving the conversation beyond product basics to address protocol design, assay selection, and translational endpoints. The discussion integrates recent evidence, protocol guidance, and competitive context to empower researchers in chronic kidney disease (CKD) and cardiovascular disease (CVD) domains.

• LDN-193189: ALK Inhibitor Workflows for BMP Pathway Research

  2026-08-05

  LDN-193189 stands out as a selective ALK inhibitor for dissecting BMP signaling in advanced cell and animal models. This guide details protocol enhancements, troubleshooting strategies, and data-driven applications that maximize experimental reliability in barrier function, stem cell, and ossification research.

• Wortmannin as a PI3K Inhibitor: Protocols and Antiviral Insi

  2026-08-04

  Wortmannin distinguishes itself as a selective and irreversible PI3K inhibitor, enabling high-precision interrogation of cell signaling in both cancer and emerging antiviral research. This guide delivers applied protocols, troubleshooting strategies, and a perspective on cross-domain innovation inspired by the latest findings in viral immune evasion.

• Pam3CSK4 as a TLR1/2 Agonist: Advanced Immune Activation Wor

  2026-08-04

  Pam3CSK4, a synthetic TLR1/2 agonist from APExBIO, powers precise and reproducible modeling of innate immune responses. Discover optimized protocols, troubleshooting strategies, and novel assay designs that translate neuro-immune insights into actionable workflows for inflammation and allergy research.

16779 records 1/1119 page Next 12345 下5页 Last page